Primary Site >> Colorectal Cancer
Gene >> CD163
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival. PMID: 18047662 |
Ref: Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time. PMID: 19582880 |
Ref: Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles. PMID: 20664940 Ref: Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL12. PMID: 20946648 Ref: TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal cancer. PMID: 21179245 |
Ref: Expression of macrophage antigens by tumor cells. PMID: 21506012 Ref: Dendritic cell and macrophage infiltration in microsatellite-unstable and microsatellite-stable colorectal cancer. PMID: 21598004 Ref: Prognostic role of CD10(+) myeloid cells in association with tumor budding at the invasion front of colorectal cancer. PMID: 21599811 Ref: Activation of tumor-promoting type 2 macrophages by EGFR-targeting antibody cetuximab. PMID: 21788356 |
Ref: Myeloid cells positive for CD10 at invasion front can predict poor outcome in stage II colorectal cancer. PMID: 21773689 Ref: Prognostic impact of beta-2-microglobulin expression in colorectal cancers stratified by mismatch repair status. PMID: 22859396 Ref: The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer. PMID: 23077543 |
Ref: Cancer-associated fibroblast and M2 macrophage markers together predict outcome in colorectal cancer patients. PMID: 23298232 Ref: Expression of CD163 prevents apoptosis through the production of granulocyte colony-stimulating factor in meningioma. PMID: 23539121 Ref: Correlations of tumor-associated macrophage subtypes with liver metastases of colorectal cancer. PMID: 23621176 Ref: Increased Th17-inducing activity of CD14+ CD163 low myeloid cells in intestinal lamina propria of patients with Crohn's disease. PMID: 23993972 Ref: Identification of miR-30e* regulation of Bmi1 expression mediated by tumor-associated macrophages in gastrointestinal cancer. PMID: 24312366 |
Ref: Macrophage expression of tartrate-resistant acid phosphatase as a prognostic indicator in colon cancer. PMID: 24429833 Ref: Immune escape mechanisms in colorectal cancer pathogenesis and liver metastasis. PMID: 24741617 Ref: Macrophage Infiltration in Tumor Stroma is Related to Tumor Cell Expression of CD163 in Colorectal Cancer. PMID: 24771466 |
Ref: Can macrophages within the microenvironment of locally invasive rectal cancers predict response to radiotherapy? PMID: 26312909 Ref: Evaluation of immune cell markers in tumor tissue treated with radioimmunotherapy in an immunocompetent rat colon carcinoma model. PMID: 26374556 Ref: Secreted Factors from Colorectal and Prostate Cancer Cells Skew the Immune Response in Opposite Directions. PMID: 26503803 Ref: A Higher Frequency of CD14+ CD169+ Monocytes/Macrophages in Patients with Colorectal Cancer. PMID: 26509874 Ref: Macrophage traits in cancer cells are induced by macrophage-cancer cell fusion and cannot be explained by cellular interaction. PMID: 26585897 |
Ref: Cancer-Associated Immune Resistance and Evasion of Immune Surveillance in Colorectal Cancer. PMID: 27006653 Ref: Phenotyping of tumor-associated macrophages in colorectal cancer: Impact on single cell invasion (tumor budding) and clinicopathological outcome. PMID: 27141391 Ref: Feedback mechanisms between M2 macrophages and Th17 cells in colorectal cancer patients. PMID: 27235120 Ref: The Immune Landscapes of Polypoid and Nonpolypoid Precancerous Colorectal Lesions. PMID: 27441558 Ref: Stromal CCR6 drives tumor growth in a murine transplantable colon cancer through recruitment of tumor-promoting macrophages. PMID: 27622061 Ref: Immunoscore encompassing CD3+ and CD8+ T cell densities in distant metastasis is a robust prognostic marker for advanced colorectal cancer. PMID: 27835889 |
Ref: Vascular endothelial growth factor A amplification in colorectal cancer is associated with reduced M1 and M2 macrophages and diminished PD-1-expressing lymphocytes. PMID: 28403223 Ref: Intratumoral Fusobacterium nucleatum abundance correlates with macrophage infiltration and CDKN2A methylation in microsatellite-unstable colorectal carcinoma. PMID: 28597080 Ref: Neutrophil infiltration is a favorable prognostic factor in early stages of colon cancer. PMID: 28882699 Ref: Pro-inflammatory chitosan/poly(gamma-glutamic acid) nanoparticles modulate human antigen-presenting cells phenotype and revert their pro-invasive capacity. PMID: 28919508 Ref: Morphological and Functional Changes in the Peritumoral Adipose Tissue of Colorectal Cancer Patients. PMID: 29086519 |
Ref: Clinical significance of programmed cell death-ligand 1 expression and the immune microenvironment at the invasive front of colorectal cancers with high microsatellite instability. PMID: 29044503 Ref: Identification of mannose receptor and CD163 as novel biomarkers for colorectal cancer. PMID: 29226859 Ref: Potential immune priming of the tumor microenvironment with FOLFOX chemotherapy in locally advanced rectal cancer. PMID: 29872576 Ref: The distribution of intratumoral macrophages correlates with molecular phenotypes and impacts prognosis in colorectal carcinoma. PMID: 29906313 Ref: Topography of cancer-associated immune cells in human solid tumors. PMID: 30179157 Ref: Colon cancer-derived conditioned medium induces differentiation of THP-1 monocytes into a mixed population of M1/M2 cells. PMID: 30183516 Ref: PD-L1/PD-1 crosstalk in colorectal cancer: are we targeting the right cells? PMID: 30285662 |